(Q38059626)

28 August 2017

Imaging hypoxia to improve radiotherapy outcome (English)

1 reference

28 August 2017

0 references

0 references

Michael R Horsman

1

0 references

author name string

Lise Saksø Mortensen

2

1 reference

28 August 2017

Jørgen B Petersen

3

1 reference

28 August 2017

Morten Busk

4

1 reference

28 August 2017

Jens Overgaard

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

Nature Reviews Clinical Oncology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

674-687

1 reference

28 August 2017

12

1 reference

Exploring the role of cancer stem cells in radioresistance

28 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

The histological structure of some human lung cancers and the possible implications for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxic radiosensitization: adored and ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

The tumor microenvironment and metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hyperthermia: a potent enhancer of radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Strategies for biologic image-guided dose escalation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Intensity modulating and other radiation therapy devices for dose painting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Theragnostic imaging for radiation oncology: dose-painting by numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia dose painting by numbers: a planning study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Resolution in PET hypoxia imaging: voxel size matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

PET imaging of hypoxia using [18F]HX4: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the pu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patien

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Radiosynthesis of three [11C]ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Imaging tumor hypoxia by magnetic resonance methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Electron paramagnetic resonance imaging of tumor pO₂.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Clinical applications of EPR: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

18FFluoroazomycinarabinofuranoside (18FAZA) and 18FFluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Initial evaluation of dynamic human imaging using 18F-FRP170 as a new PET tracer for imaging hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia in Prostate Cancer: Correlation of BOLD-MRI With Pimonidazole Immunohistochemistry—Initial Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Acute versus chronic hypoxia: why a simplified classification is simply not enough

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

The time interval after pulsed irradiation within which injury to bacteria can be modified by dissolved oxygen. I. A search for an effect of oxygen 0.02 second after pulsed irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Inducible repair and the two forms of tumour hypoxia--time for a paradigm shift

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Measurement of tumor oxygenation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.171

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

31 March 2020

1 reference

12 December 2020

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

1 reference

12 December 2020

Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma

1 reference

12 December 2020

Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.

1 reference

12 December 2020

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

1 reference

12 December 2020

A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy

1 reference

12 December 2020

Human tumor blood flow is enhanced by nicotinamide and carbogen breathing.

1 reference

12 December 2020

Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

1 reference

12 December 2020

Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1.

1 reference

12 December 2020

Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT

1 reference

12 December 2020

Pharmacokinetics of [18F]FETNIM: a potential marker for PET.

1 reference

12 December 2020

PET imaging of hypoxia.

1 reference

12 December 2020

Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole

1 reference

12 December 2020

Prolonged tumor dormancy by prevention of neovascularization in the vitreous

1 reference

12 December 2020

Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside

1 reference

12 December 2020

Intermittent blood flow in a murine tumor: radiobiological effects

1 reference

12 December 2020

Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy

1 reference

12 December 2020

10.1038/NRCLINONC.2012.171

Identifiers

DOI

1 reference

28 August 2017

1 reference